Find Experts

Experts in Immunology
Priti Bajpai M.J.M. (MARC) BONTEN Rolee Sharma Douglas Darling Donald Demuth Alba Ruiz de Andrés Javier Martínez-Picado Prof. Sarat Kumar Dalai Prof. Sarat Kumar Dalai Julià Blanco Cezmi A. Akdis Dr Joanna Kirman Arianna Calcinotto Dennis W. McGee Liz Hedstrom Daniela Brina Joan Press Neil E. Simister Mausumi Sikdar (Nee Bhakta )  Asmita Das View More
Frank Waldron-Lynch

Principle Investigator
Experimental Medicine and Immunotherapeutics 
Cambridge University
United Kingdom

Scientist Immunology
Biography

Dr. Frank Waldron-Lynch is affiliated to the Department of Experimental Medicine and Immunotherapeutics , Cambridge University. Dr. Frank Waldron-Lynch is currently providing services as Principle Investigator. Dr. Frank Waldron-Lynch has published numerous publications in various national and international peer-reviewed journals and presented scientific papers across the world. Because of the active association with different societies and academies as well as the contributions, Dr. Frank Waldron-Lynch is been recognized by the subject experts around the world. Dr. Frank Waldron-Lynch contributions are appreciated by various reputed awards. Dr. Frank Waldron-Lynch clinical and scientific research interests include Pre-Clinical Modelling Of Human Immunotherapy In Vivo, Experimental Medicine, Autoimmune Diseases, Adaptive Trial Design, Immunotherapy, Autoimmunity, Immunotherapeutics, Biomarkers, Stratified Medicine, Medical Genetics, Translational Immunology, Immunogenetics, Stratification Of Patients By Genotype And Immunophenotypes, Metabolism, Design And Conduct Of Clinical Trials Of Immunotherapy.

Research Intrest

Pre-Clinical Modelling Of Human Immunotherapy In Vivo, Experimental Medicine, Autoimmune Diseases, Adaptive Trial Design, Immunotherapy, Autoimmunity, Immunotherapeutics, Biomarkers, Stratified Medicine, Medical Genetics, Translational Immunology, Immunogenetics, Stratification Of Patients By Genotype And Immunophenotypes, Metabolism, Design And Conduct Of Clinical Trials Of Immunotherapy

List of Publications
Waldron-Lynch F, Kareclas P, Irons K, Walker NM, Mander A, Wicker LS, Todd JA, Bond S. Rationale and study design of the Adaptive study of IL-2 dose on regulatory T cells in type 1 diabetes (DILT1D): a non-randomised, open label, adaptive dose finding trial. BMJ open. 2014 Jun 1;4(6):e005559.
Heywood J, Evangelou M, Goymer D, Kennet J, Anselmiova K, Guy C, O’Brien C, Nutland S, Brown J, Walker NM, Todd JA. Effective recruitment of participants to a phase I study using the internet and publicity releases through charities and patient organisations: analysis of the adaptive study of IL-2 dose on regulatory T cells in type 1 diabetes (DILT1D). Trials. 2015 Mar 11;16(1):86.
Todd JA, Evangelou M, Cutler AJ, Pekalski ML, Walker NM, Stevens HE, Porter L, Smyth DJ, Rainbow DB, Ferreira RC, Esposito L. Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial. PLoS medicine. 2016 Oct 11;13(10):e1002139.
Experts in United Kingdom
Ian Weeks Dr Steve Riley M H FERRI ALIABADI Simon Jones DR GIULIANOALLEGRI Michael Owen PETER BEARMAN Dr Richard Adams DR PAUL BRUCE Robert Lee Mansour Moniri Paul Hackett Dr Ameer Al-Nemrat Dr Jawed Qureshi Miss Sarah Catmur Mark Banfield Janneke Balk Arya Assadi Langroudi Rob Field George Lomonossoff Tony Maxwell Sarah OConnor Robert Sablowski Stephen de Mora Susan Brind View More